Zakrzewski Joseph S Insider Trades

Insider Trading History

Track insider trading activity for Zakrzewski Joseph S. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $417k 99,999 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$524k 134,103 shares
$3.91
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $0 0 shares
Last Trade
Mar 19, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$524k 134,103 shares
$3.91
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $85.1k 20,400 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.2k 20,400 shares
$1.04
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $79.7k 19,111 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.7k 19,111 shares
$1.19
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $607k 145,538 shares
Last Trade
Apr 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.7k 10,523 shares
$1.21
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $563k 135,015 shares
Last Trade
Dec 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.2k 9,816 shares
$1.34
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $522k 125,199 shares
Last Trade
Nov 27, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.8k 2,000 shares
$1.40
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $514k 123,199 shares
Last Trade
Nov 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.05k 5,000 shares
$1.01
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $493k 118,199 shares
Last Trade
Nov 18, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20k 20,000 shares
$1.00
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $269k 64,503 shares
Last Trade
Jun 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 64,503 shares
$2.00
$4.17
Cyteir Therapeutics
Cyteir Therapeutics CYT
Director
Holding Value $687k 227,439 shares
Last Trade
Feb 06, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$44.2k 14,150 shares
$3.12
$3.02
Cyteir Therapeutics
Cyteir Therapeutics CYT
Director
Holding Value $0 0 shares
Last Trade
Feb 06, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$44.2k 14,150 shares
$3.12
$3.02
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $1.69M 405,880 shares
Last Trade
Jan 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.91M 100,000 shares
$19.11
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $99k 23,742 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 23,742 shares
$5.91
$4.17
Cyteir Therapeutics
Cyteir Therapeutics CYT
Director
Holding Value $42.7k 14,150 shares
Last Trade
Feb 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.9k 14,150 shares
$1.69
$3.02
Cyteir Therapeutics
Cyteir Therapeutics CYT
Director
Holding Value $467k 154,618 shares
Last Trade
Dec 07, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$27.6k 21,202 shares
$1.30
$3.02
Cyteir Therapeutics
Cyteir Therapeutics CYT
Director
Holding Value $403k 133,416 shares
Last Trade
May 12, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.2k 743 shares
$1.61
$3.02
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $43.2k 10,362 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179k 10,362 shares
$17.28
$4.17
Cyteir Therapeutics
Cyteir Therapeutics CYT
Director
Holding Value $398k 131,673 shares
Last Trade
May 10, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$93.4k 49,406 shares
$1.89
$3.02
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $409k 98,199 shares
Last Trade
Mar 29, 2022 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.47M 98,199 shares
$15.01
$4.17

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up